{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:59:41Z","timestamp":1780120781555,"version":"3.54.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Uterine serous carcinoma (USC) typically arises from atrophic endometrium but may be associated with hyperplasia in 5% to 10% of cases. We sought to identify USC with concurrent hyperplasia and (i) define if these are clonally related, and (ii) determine if USC associated with hyperplasia is genetically distinct from USC without hyperplasia. Patients diagnosed with USC and hyperplasia from their hysterectomy specimen between January 1, 2014 and February 29, 2022 were identified. Hyperplasia and carcinoma were separately subjected to tumor-normal panel sequencing. Their repertoire of genetic alterations was compared with that of a separate cohort of atrophy-associated USCs. Of 267 USCs with clinical sequencing and slides available for review, 8 with concurrent carcinoma and hyperplasia had sufficient tissue for molecular studies. In 7 (87.5%) of these 8 cases, USC and hyperplasia were clonally related and shared multiple mutations, including <jats:italic toggle=\"yes\">TP53<\/jats:italic> in 4 cases (57%). In 1 case (USC4), USC and hyperplasia were unrelated at the genetic level, and the hyperplasia was <jats:italic toggle=\"yes\">TP53<\/jats:italic> wild-type. In another case (USC5), USC and <jats:italic toggle=\"yes\">TP53<\/jats:italic> wild-type hyperplasia shared 1 of 11 mutations while being distinct at the copy number level. The prevalence of <jats:italic toggle=\"yes\">ARID1A<\/jats:italic> mutations was higher in hyperplasia-associated USC compared with atrophy-associated USC (43% vs. 0%, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02). USC and co-occurring hyperplasia were clonally related in most cases, commonly harboring <jats:italic toggle=\"yes\">TP53<\/jats:italic> hotspot mutations in both components. These results suggest an alternative origin of tumorigenesis in this rare subset of endometrial cancers.<\/jats:p>","DOI":"10.1097\/pas.0000000000002401","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:00:08Z","timestamp":1745917208000},"page":"753-762","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic and Genomic Analysis of Uterine Serous Carcinomas Arising From Endometrial Hyperplasia"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-207X","authenticated-orcid":false,"given":"Tiffany Y.","family":"Sia","sequence":"first","affiliation":[{"name":"Department of Surgery, Gynecology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas H.R.","family":"Allison","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"},{"name":"i3S Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edaise M.","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Selenica","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fresia","family":"Pareja","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gynecology Service"},{"name":"Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Ellenson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GCO.0b013e328334d8a3","article-title":"Uterine papillary serous carcinoma: epidemiology, pathogenesis and management","volume":"22","author":"Fader","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2005.11.009","article-title":"The effect of age on clinical\/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer","volume":"101","author":"Lachance","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ijgc-2021-002753","article-title":"Uterine serous carcinoma: key advances and novel treatment approaches","volume":"31","author":"Ferriss","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/modpathol.2015.141","article-title":"Practical issues in the diagnosis of serous carcinoma of the endometrium","volume":"29","author":"Gatius","year":"2016","journal-title":"Mod Pathol"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cncr.11484","article-title":"Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus","volume":"98","author":"Sherman","year":"2003","journal-title":"Cancer"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/1055-9965.EPI-15-0316","article-title":"The growing burden of endometrial cancer: a major racial disparity affecting Black Women","volume":"24","author":"Cote","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e318202772e","article-title":"A proposed model for endometrial serous carcinogenesis","volume":"35","author":"Zheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/106689690401200302","article-title":"Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features","volume":"12","author":"Zheng","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum Pathol"},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.1222577110","article-title":"Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc Ntnl Acad Sci"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2009.11.012","article-title":"Molecular alterations in uterine serous carcinoma","volume":"116","author":"Hayes","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0b013e318273732e","article-title":"Pure compared with mixed serous endometrial carcinoma: two different entities?","volume":"120","author":"Roelofsen","year":"2012","journal-title":"Obstetr Gynecol"},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41379-021-00997-2","article-title":"Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas","volume":"35","author":"Ross","year":"2022","journal-title":"Mod Pathol"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41379-020-0514-3","article-title":"Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary","volume":"33","author":"Da Cruz Paula","year":"2020","journal-title":"Mod Pathol"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nmeth.3069","article-title":"Accurate de novo and transmitted indel detection in exome-capture data using microassembly","volume":"11","author":"Narzisi","year":"2014","journal-title":"Nat Methods"},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/2159-8290.CD-17-0321","article-title":"Accelerating discovery of functional mutant alleles in cancer.","volume":"8","author":"Chang","year":"2018","journal-title":"Cancer Discov"},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2021.02.015","article-title":"Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer","volume":"161","author":"Da Cruz Paula","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/jnci\/djs345","article-title":"Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses","volume":"104","author":"Kuhn","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00000478-199812000-00003","article-title":"p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma","volume":"22","author":"Zheng","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R26-20250728","first-page":"177","article-title":"p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis","volume":"150","author":"Tashiro","year":"1997","journal-title":"Am J Pathol"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/ijgc-2022-003430","article-title":"Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series","volume":"32","author":"Sia","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R30-20250728","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/modpathol.2013.96","article-title":"Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer","volume":"26","author":"Bosse","year":"2013","journal-title":"Mod Pathol"},{"key":"R32-20250728","doi-asserted-by":"crossref","first-page":"e1009986","DOI":"10.1371\/journal.pgen.1009986","article-title":"Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis","volume":"17","author":"Reske","year":"2021","journal-title":"PLoS Genet"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:00:33Z","timestamp":1753700433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002401","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}